Search research articles
Contact Us
Filters
Showing results (491-500 of 517) with videos related to
Page
of 52
Sort By:
Clinical and Experimental Immunology
|
November 13, 2001
Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95
J M Shaw, A Al-Shamkhani, L A Boxer, et al.
Cell Stem Cell
|
November 22, 2012
CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα
Guangwen Ren, Xin Zhao, Ying Wang, et al.
Leukemia
|
December 17, 2013
GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
A Maroz, L Stachorski, S Emmrich, et al.
Stem Cells (Dayton, Ohio)
|
October 15, 2013
An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells
Qing Chen, Peishun Shou, Liying Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 3, 2026
Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada
Nathan Y Chu, Jodie I Roberts, David J Hunt, et al.
Oncogene
|
August 27, 2013
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y Huang, P Yu, W Li, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 17, 2016
The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis
Kirsten M Fiest, Nathalie Jetté, Jodie I Roberts, et al.
Oncogene
|
October 31, 1998
Homozygous deletions at 3p12 in breast and lung cancer
V Sundaresan, G Chung, A Heppell-Parton, et al.
Cell Reports
|
November 17, 2016
SHP1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Differentiation
Menghui Jiang, Chunxing Zheng, Peishun Shou, et al.
Bone Marrow Transplantation
|
May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
A J Innes, R Beattie, R Sergeant, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 517) with videos related to
Sort By:
Page
of 52
Clinical and Experimental Immunology
|
November 13, 2001
Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95
J M Shaw, A Al-Shamkhani, L A Boxer, et al.
Cell Stem Cell
|
November 22, 2012
CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα
Guangwen Ren, Xin Zhao, Ying Wang, et al.
Leukemia
|
December 17, 2013
GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
A Maroz, L Stachorski, S Emmrich, et al.
Stem Cells (Dayton, Ohio)
|
October 15, 2013
An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells
Qing Chen, Peishun Shou, Liying Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 3, 2026
Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada
Nathan Y Chu, Jodie I Roberts, David J Hunt, et al.
Oncogene
|
August 27, 2013
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y Huang, P Yu, W Li, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 17, 2016
The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis
Kirsten M Fiest, Nathalie Jetté, Jodie I Roberts, et al.
Oncogene
|
October 31, 1998
Homozygous deletions at 3p12 in breast and lung cancer
V Sundaresan, G Chung, A Heppell-Parton, et al.
Cell Reports
|
November 17, 2016
SHP1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Differentiation
Menghui Jiang, Chunxing Zheng, Peishun Shou, et al.
Bone Marrow Transplantation
|
May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
A J Innes, R Beattie, R Sergeant, et al.
Page
of 52